on Cambrex
Cambrex Milan Launches $30 Million R&D Facility for 80th Anniversary
Cambrex, a leading contract development and manufacturing organization, has commenced the construction of a new R&D facility in Milan, Italy. This $30 million project marks a significant investment in advanced analytical development and process R&D capabilities. The expansion aligns with Cambrex's strategy to enhance small molecule pharmaceutical development.
The completion of the Milan R&D facility is anticipated in the latter half of 2027. Cambrex has secured additional land adjacent to the site to support future expansion. This move underscores Cambrex's dedication to innovation and meeting the rising demand for CDMO services.
Celebrating its 80th anniversary, the Cambrex Profarmico Milano site has a long-standing history in pharmaceutical manufacturing. Claudio Russolo, COO at Cambrex, highlights the development as a tribute to Milan's enduring legacy and expertise.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Cambrex news